Professor Robert Hawkins is a Consultant Medical Oncologist at The Christie NHS Trust in Manchester and he also sees patients privately at The Christie Private Care. His specialist interests include adrenal cancer, kidney cancer, melanoma and soft tissue cancer.
He focuses on immunotherapy as a treatment for cancer, including the delivery of high does interleukin-2 as a potentially curative treatemetn for selected patients with renal cancer. He also undertakes Phase I/II trials of immune and other biological therapies in a wider range of cancers including gastrointestinal cancers, melanoma and B cell lymphomas as well as renal cancers.
In addition, adoptive cellular therapy is the major translational research interest of Professor Hawkins who leads the EU 'ATTACK' programme and the EU 'ATTRACT' training network (www.attack-cancer.org), which links leading European researchers in the engineered T-cell field.
He has established a specialist Cellular Therapy Laboratory Unit in Manchester, which currently supports trials/treatments of cellular therapy for B-cell malignancies and melanoma. Further, he hass published widely on clinical/translational cancer research and is on several research committees.
Professor Hawkins attended medical school at Cambridge University and University College London and then undertook medical oncology training at the Royal Marsden and Addenbrooke’s Hospitals. He attained a PhD in antibody engineering at the MRC Laboratory of Molecular Biology in Cambridge.